-
1
-
-
0019988248
-
Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer
-
Clark OH (1982) Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 196: 361-370
-
(1982)
Ann Surg
, vol.196
, pp. 361-370
-
-
Clark, O.H.1
-
2
-
-
0032535770
-
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the USA, 1985-1995
-
Hundahl SA, Fleming ID, Fremgen AM (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the USA, 1985-1995. Cancer 83: 2638-2648
-
(1998)
Cancer
, vol.83
, pp. 2638-2648
-
-
Hundahl, S.A.1
Fleming, I.D.2
Fremgen, A.M.3
-
3
-
-
1642392071
-
Implications of prognostic factors and risk groups in the managment of differentiated thyroid cancer
-
Shaha AR (2004) Implications of prognostic factors and risk groups in the managment of differentiated thyroid cancer. Laryngoscope 114: 393-402
-
(2004)
Laryngoscope
, vol.114
, pp. 393-402
-
-
Shaha, A.R.1
-
4
-
-
0030788411
-
The urokinase-type plasminogen activator system in cancer metastasis: A review
-
Andreasen PA, Kjöller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22
-
(1997)
Int J Cancer
, vol.72
, pp. 1-22
-
-
Andreasen, P.A.1
Kjöller, L.2
Christensen, L.3
Duffy, M.J.4
-
5
-
-
0019850184
-
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glucoprotein and collagenous components of basement membrane
-
Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Gabrisa BM (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glucoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636
-
(1981)
Cancer Res
, vol.41
, pp. 4629-4636
-
-
Liotta, L.A.1
Goldfarb, R.H.2
Brundage, R.3
Siegal, G.P.4
Terranova, V.5
Gabrisa, B.M.6
-
6
-
-
0021780949
-
Plasminogen activators, tissue degradation and cancer
-
Danø K, Andersen PA, Grondhal-Hansen J, Kristensen P, Nielsen IS, Skriver L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139-146
-
(1985)
Adv Cancer Res
, vol.44
, pp. 139-146
-
-
Danø, K.1
Andersen, P.A.2
Grondhal-Hansen, J.3
Kristensen, P.4
Nielsen, I.S.5
Skriver, L.6
-
7
-
-
0030857717
-
Clinical impact of the plasminogen activation system in tumor invasion and metastasis: Prognostic relevance and target for therapy
-
Schmitt M, Harbeck N, Thomsen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Höfler H, Jänicke F, Graeff H (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78: 285-296
-
(1997)
Thromb Haemost
, vol.78
, pp. 285-296
-
-
Schmitt, M.1
Harbeck, N.2
Thomsen, C.3
Wilhelm, O.4
Magdolen, V.5
Reuning, U.6
Ulm, K.7
Höfler, H.8
Jänicke, F.9
Graeff, H.10
-
8
-
-
0032882381
-
Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: Role of the plasmin activation sytem
-
Smit JW, van der Pluijm G, Romijn HA, Lowik CW, Morreau H, Goslings BM (1999) Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation sytem. Thyroid 9: 913-919
-
(1999)
Thyroid
, vol.9
, pp. 913-919
-
-
Smit, J.W.1
van der Pluijm, G.2
Romijn, H.A.3
Lowik, C.W.4
Morreau, H.5
Goslings, B.M.6
-
9
-
-
0029870599
-
Plasminogen activation system is active even in thyroid tumors: An immunohistochemical study
-
Ito Y, Takeda T, Kobayashi T, Wakasugi E, Tamaki Y, Umeshita K, et al (1996) Plasminogen activation system is active even in thyroid tumors: An immunohistochemical study. Anticancer Res 16: 81-90
-
(1996)
Anticancer Res
, vol.16
, pp. 81-90
-
-
Ito, Y.1
Takeda, T.2
Kobayashi, T.3
Wakasugi, E.4
Tamaki, Y.5
Umeshita, K.6
-
10
-
-
0019083094
-
Breast Cancer Cooperative Group Revision of the standards for the assessment of hormone receptors in human breast cancer
-
EORTC
-
EORTC (1980) Breast Cancer Cooperative Group Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1515
-
(1980)
Eur J Cancer
, vol.16
, pp. 1513-1515
-
-
-
11
-
-
0028358771
-
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1
-
Jänicke F, Pache L, Schmitt M, Ulm K, Thomssen C, Prechtl A, Graeff H (1994) Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1. Cancer Res 54: 2527-2530
-
(1994)
Cancer Res
, vol.54
, pp. 2527-2530
-
-
Jänicke, F.1
Pache, L.2
Schmitt, M.3
Ulm, K.4
Thomssen, C.5
Prechtl, A.6
Graeff, H.7
-
12
-
-
0034041973
-
Thyroid cancer: Extent of thyroidectomy
-
Shaha AR (2000) Thyroid cancer: Extent of thyroidectomy. Cancer Control 7: 240-245
-
(2000)
Cancer Control
, vol.7
, pp. 240-245
-
-
Shaha, A.R.1
-
13
-
-
0021669783
-
Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy
-
Cohn KH, Backdahl M, Forsslund G (1984) Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 96: 957-991
-
(1984)
Surgery
, vol.96
, pp. 957-991
-
-
Cohn, K.H.1
Backdahl, M.2
Forsslund, G.3
-
14
-
-
4444266968
-
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States
-
Haigh PI, Urbach DR, Rotstein LE (2004) AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery 136: 609-616
-
(2004)
Surgery
, vol.136
, pp. 609-616
-
-
Haigh, P.I.1
Urbach, D.R.2
Rotstein, L.E.3
-
15
-
-
0018648251
-
A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group
-
Byar DP, Green SB, Dor P (1979) A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 15: 1033-1041
-
(1979)
Eur J Cancer
, vol.15
, pp. 1033-1041
-
-
Byar, D.P.1
Green, S.B.2
Dor, P.3
-
16
-
-
0023521529
-
Ispilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system
-
Hay ID, Grant CS, Taylor WF (1987) Ispilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102: 1088-1095
-
(1987)
Surgery
, vol.102
, pp. 1088-1095
-
-
Hay, I.D.1
Grant, C.S.2
Taylor, W.F.3
-
17
-
-
0027135424
-
Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
-
Hay ID, Bergstrahl EJ, Goellner JR (1993) Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1058
-
(1993)
Surgery
, vol.114
, pp. 1050-1058
-
-
Hay, I.D.1
Bergstrahl, E.J.2
Goellner, J.R.3
-
18
-
-
3042826468
-
Prognostic Scoring systems in patients with follicular thyroid cancer: A comparison of different staging systems in predicting the patient outcome
-
D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wong JM, Duh QY, Siperstein AE, Clark OH (2004) Prognostic Scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 14: 453-458
-
(2004)
Thyroid
, vol.14
, pp. 453-458
-
-
D'Avanzo, A.1
Ituarte, P.2
Treseler, P.3
Kebebew, E.4
Wong, J.M.5
Duh, Q.Y.6
Siperstein, A.E.7
Clark, O.H.8
-
19
-
-
0034080079
-
Prognostic Indicators in differentiated thyroid carcinoma
-
Dean DS, Hay ID (2000) Prognostic Indicators in differentiated thyroid carcinoma. Cancer Control 7: 229-239
-
(2000)
Cancer Control
, vol.7
, pp. 229-239
-
-
Dean, D.S.1
Hay, I.D.2
-
20
-
-
0031028402
-
Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the Surveillance, Epidemiology and results (SEER) program, 1973-1991
-
Gilland FD, Hunt WC, Morris DM (1997) Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and results (SEER) program, 1973-1991. Cancer 79: 564-573
-
(1997)
Cancer
, vol.79
, pp. 564-573
-
-
Gilland, F.D.1
Hunt, W.C.2
Morris, D.M.3
-
21
-
-
0025715140
-
Prognostic factors in highly malignant thyroid tumors
-
Hollinsky C, Kober F, Hermann M, Loicht U, Keminger K (1990) Prognostic factors in highly malignant thyroid tumors. Wien Klin Wochenschr 27: 102: 249-253
-
(1990)
Wien Klin Wochenschr
, vol.27
, Issue.102
, pp. 249-253
-
-
Hollinsky, C.1
Kober, F.2
Hermann, M.3
Loicht, U.4
Keminger, K.5
-
22
-
-
0027943619
-
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
-
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418-428
-
(1994)
Am J Med
, vol.97
, pp. 418-428
-
-
Mazzaferri, E.L.1
Jhiang, S.M.2
-
23
-
-
0037369140
-
Prognostic factors in patients with Hürthle cell neoplasms of the thyroid
-
Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordonez NG, Sherman SI (2003) Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97: 1186-1194
-
(2003)
Cancer
, vol.97
, pp. 1186-1194
-
-
Lopez-Penabad, L.1
Chiu, A.C.2
Hoff, A.O.3
Schultz, P.4
Gaztambide, S.5
Ordonez, N.G.6
Sherman, S.I.7
-
24
-
-
0033968403
-
The urokinase system of plasminogen activation and prognosis in 2,780 breast cancer patients
-
Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer M, et al (2000) The urokinase system of plasminogen activation and prognosis in 2,780 breast cancer patients. Cancer Res 60: 636-643
-
(2000)
Cancer Res
, vol.60
, pp. 636-643
-
-
Foekens, J.A.1
Peters, H.A.2
Look, M.P.3
Portengen, H.4
Schmitt, M.5
Kramer, M.6
-
25
-
-
0024428950
-
Urokinase-type plasminogen activator antigen and early relapse in breast cancer
-
Jänicke F, Schmitt M, Ulm K, Gossner W, Graeff H (1989) Urokinase-type plasminogen activator antigen and early relapse in breast cancer. Lancet 2: 1049
-
(1989)
Lancet
, vol.2
, pp. 1049
-
-
Jänicke, F.1
Schmitt, M.2
Ulm, K.3
Gossner, W.4
Graeff, H.5
-
26
-
-
1842296358
-
High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma
-
Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS (1997) High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. Cancer 79: 878-883
-
(1997)
Cancer
, vol.79
, pp. 878-883
-
-
Cho, J.Y.1
Chung, H.C.2
Noh, S.H.3
Roh, J.K.4
Min, J.S.5
Kim, B.S.6
-
27
-
-
0028070859
-
Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamos and large cell lung cancer tissue
-
Pedersen H, Brunner N, Francis D, Osterlind K, Ronne E, Hansen HH, et al (1994) Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamos and large cell lung cancer tissue. Cancer Res 54: 4671-4675
-
(1994)
Cancer Res
, vol.54
, pp. 4671-4675
-
-
Pedersen, H.1
Brunner, N.2
Francis, D.3
Osterlind, K.4
Ronne, E.5
Hansen, H.H.6
-
28
-
-
0027935805
-
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
-
Ganesh S, Sier CF, Griffioen G, Vloedgraven HJ, de Boer A, Welvaart K, et al (1994) Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 54: 4065-4071
-
(1994)
Cancer Res
, vol.54
, pp. 4065-4071
-
-
Ganesh, S.1
Sier, C.F.2
Griffioen, G.3
Vloedgraven, H.J.4
de Boer, A.5
Welvaart, K.6
-
29
-
-
0029898212
-
Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma
-
Hofmann R, Lehmer A, Buresh M, Hartung R, Ulm K (1996) Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma. Cancer (Phila) 78: 487-492
-
(1996)
Cancer (Phila)
, vol.78
, pp. 487-492
-
-
Hofmann, R.1
Lehmer, A.2
Buresh, M.3
Hartung, R.4
Ulm, K.5
-
30
-
-
0033055316
-
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
-
Kuhn W, Schalfeldt B, Reuning U, Pache L, Berger U, Ulm K, et al (1999) Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer 79: 1746-1751
-
(1999)
Br J Cancer
, vol.79
, pp. 1746-1751
-
-
Kuhn, W.1
Schalfeldt, B.2
Reuning, U.3
Pache, L.4
Berger, U.5
Ulm, K.6
-
31
-
-
0032520105
-
Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma
-
Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1998) Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma. Cancer 82: 724-732
-
(1998)
Cancer
, vol.82
, pp. 724-732
-
-
Nakanishi, K.1
Kawai, T.2
Torikata, C.3
Aurues, T.4
Ikeda, T.5
-
32
-
-
0028639208
-
Impact of urokinase type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus
-
Kobayashi H, Fujishiro S, Terao T (1994) Impact of urokinase type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res 54: 6539-6548
-
(1994)
Cancer Res
, vol.54
, pp. 6539-6548
-
-
Kobayashi, H.1
Fujishiro, S.2
Terao, T.3
-
33
-
-
0029019715
-
Expression of urokinase-type plasminogen activator in various human thyroid tissues
-
2: 525-528
-
Ito Y, Takeda T, Wakasugi E, Umeshita K, Fukuda H, Monden T, et al (1995) Expression of urokinase-type plasminogen activator in various human thyroid tissues. Oncology Reports 2: 525-528
-
(1995)
Oncology Reports
-
-
Ito, Y.1
Takeda, T.2
Wakasugi, E.3
Umeshita, K.4
Fukuda, H.5
Monden, T.6
-
34
-
-
9244231807
-
Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis
-
Chu QD, Hurd TC, Harvey S, Martinick M, Markus G, Tan D, et al (2004) Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis. Diagn Mol Pathol 13: 241-246
-
(2004)
Diagn Mol Pathol
, vol.13
, pp. 241-246
-
-
Chu, Q.D.1
Hurd, T.C.2
Harvey, S.3
Martinick, M.4
Markus, G.5
Tan, D.6
-
35
-
-
0033773576
-
Beneficial effects of retinoic acid on extracellular matric degradation and attachment behavior in follicular thyroid carcinoma cell lines
-
Havekes B, Schröder van der Elst JP, van der Pluijm G, Goslings BM, Morreau J, Romijin JA, Smit JWA (2000) Beneficial effects of retinoic acid on extracellular matric degradation and attachment behavior in follicular thyroid carcinoma cell lines. J Endocrinol 167: 229-238
-
(2000)
J Endocrinol
, vol.167
, pp. 229-238
-
-
Havekes, B.1
Schröder van der Elst, J.P.2
van der Pluijm, G.3
Goslings, B.M.4
Morreau, J.5
Romijin, J.A.6
Smit, J.W.A.7
-
36
-
-
0025128311
-
-
Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 546-576.1984) Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 96: 957-991
-
Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 546-576.1984) Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 96: 957-991
-
-
-
|